General Information of the Compound
| Compound ID |
CP0423714
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-N-[(3-cyclopropyl-1,2-oxazol-5-yl)methyl]-4-N-[5-(3-methoxypropyl)-1H-pyrazol-3-yl]pyrimidine-2,4-diamine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H23N7O2
|
||||||||||||||||||
| Molecular Weight |
369.429
|
||||||||||||||||||
| Canonical SMILES |
COCCCc1cc(Nc2ccnc(NCc3cc(no3)C3CC3)n2)[nH]n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H23N7O2/c1-26-8-2-3-13-9-17(24-23-13)21-16-6-7-19-18(22-16)20-11-14-10-15(25-27-14)12-4-5-12/h6-7,9-10,12H,2-5,8,11H2,1H3,(H3,19,20,21,22,23,24)
Show/Hide
|
||||||||||||||||||
| InChIKey |
WSNDHEGGDQJEPA-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01091, Fibroblast growth factor receptor 1
Protein ID: PT01104, Insulin-like growth factor 1 receptor
Protein ID: PT00864, Vascular endothelial growth factor receptor 2